Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P31749 (
AKT
)
22,954
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
BACKGROUND
Protocadherin 8
(
PCDH8
) functions as a tumor-suppressor gene in many types of cancer. This study aimed to investigate the role of
PCDH8
in esophageal squamous cell carcinoma (ESCC). MATERIAL AND METHODS Cell proliferation, apoptosis, transwell assay, tube formation assays, and tumor xenograft experiment were performed to explore the role of
PCDH8
in the progression of ESCC. RESULTS
PCDH8
was found to be downregulated in ESCC cells. Ectopic expression of
PCDH8
blocked proliferation, invasion, and migration and induced apoptosis in ESCC cells. Furthermore, vascular endothelial growth factor A (VEGFA) secretion and the
AKT
signaling pathway were also inhibited when
PCDH8
was upregulated.
PCDH8
overexpression suppressed epithelial-mesenchymal transition (EMT) and pro-angiogenic activity of ESCC cells. In a mouse model of ESCC xenograft tumors,
PCDH8
overexpression remarkably restrained tumor cell growth, with the tumor inhibition rate of 75.2%.
PCDH8
was the target of miR-200c and had a negative correlation with miR-200c. CONCLUSIONS
PCDH8
exerts a tumor-suppressive effect against ESCC cells. However, further studies are required to elucidate the exact molecular mechanism underlying the antitumor activity of
PCDH8
in ESCC.
...
PMID:Protocadherin 8 (PCDH8) Inhibits Proliferation, Migration, Invasion, and Angiogenesis in Esophageal Squamous Cell Carcinoma. 3233 Jan 23